These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6101961

  • 1. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ, Mackay AD.
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The onset of action of formoterol, a new beta 2 adrenoceptor agonist.
    Stam J, Souren M, Zweers P.
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):23-6. PubMed ID: 8095250
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Eformoterol versus salbutamol in patients with ROAD.
    Maesen FP.
    Br J Clin Pract Suppl; 1995 Sep; 81():8-10. PubMed ID: 8546895
    [No Abstract] [Full Text] [Related]

  • 12. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ, Tashkin DP, Ho D, Child JS.
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction.
    Poppius H, Lehti H, Stenius-Aarniala B.
    Eur J Clin Pharmacol; 1979 Jul; 15(6):389-93. PubMed ID: 387417
    [Abstract] [Full Text] [Related]

  • 15. Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.
    Cazzola M, Matera MG.
    Pulm Pharmacol Ther; 2003 Jul; 16(4):197-201. PubMed ID: 12850121
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
    Germouty J.
    Clin Ther; 1986 Jul; 8(5):546-53. PubMed ID: 2876775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.